CHILDREN'S CHESTAL OTC
Generic Name and Formulations:
Antimonium tartaricum 6C HPUS, Bryonia alba 3C HPUS, Coccus cacti 3C HPUS, Drosera rotundifolia 3C HPUS, Ipecacuanha 3C HPUS, Pulsatilla 6C HPUS, Rumex crispus 6C HPUS, Spongia tosta 3C HPUS, Sticta pulmonaria 3C HPUS; liq; contains honey, 4.2g of sugars per 5mL, alcohol 0.001%.
Indications for CHILDREN'S CHESTAL:
Adults and Children:
<2yrs: not recommended. 2–12yrs: 5mL every 2 hours. >12yrs: 10mL every 2 hours.
Pregnancy. Nursing mothers.
Clinical Pain Advisor Articles
- Chronic Neuropathic Pain Updated Classification by IASP for ICD-11
- Buprenorphine-Naloxone Found to Be More Cost-Effective Than Extended-Release Naltrexone
- Ultrasound-Guided C2 Coblation May Be Effective for Cervicogenic Headache
- Meta-Analysis of Opioid Treatment for Chronic Noncancer Pain
- Opioids Found to Increase Risk for Community-Acquired Pneumonia, Particularly in HIV
- Reviewing the Use of Buprenorphine in Perioperative Pain Management
- Early Physical Therapy for Musculoskeletal Pain May Reduce Opioid Use
- External Trigeminal Nerve Stimulation May Alleviate Migraine Pain
- IASP Updates Diagnosis Criteria for Chronic Primary Pain for ICD-11
- Galcanezumab Provides Persistent Preventive Effects in Episodic, Chronic Migraine
- Comparable Analgesia With Low-Dose IV Ketamine, Morphine for Acute Pain
- Benzodiazepines, if Prescribed, May Not Affect Methadone Treatment Retention
- When Opioid Prescribing Guidelines Become Rules
- IV Fluid Confers No Significant Treatment Effect on Migraine Pain
- American Headache Society Releases Position Statement on Novel Preventive and Acute Migraine Treatments